Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model

Total article views   HTML views PDF downloads Totals
3,280 Dovepress* 3,162+ 109 3,271
PubMed Central* 118 33 151
Totals 3,280 142 3,422
*Since 13 November 2021

View citations on PubMed Central and Google Scholar